These companies could innovate their way to success.

Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...

Crispr Therapeutics AG ( ($CRSP) ) has risen by 9.03%. Read on to learn why. Crispr Therapeutics AG has seen its stock price rise by 9.03% over ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this involves a beaten-down biotech stock that Wood has been buying regularly ...

CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best short squeeze stocks to buy right now. Citizens reaffirmed its Market Outperform rating and $86 price target for CRISPR Therapeutics AG ...

Genome editing has been a long goal in molecular biology, medicine, and biotechnology, dating back to the discovery of restriction enzymes. However, the identification of zinc-finger nucleases (ZFN) ...

Poco F8 Ultra will be launched in two colourways Poco F8 Pro is teased to sport a 6.59-inch display The company has yet to reveal the pricing details ...

Micron Technology (NASDAQ:MU) shares soared to an all-time high of $260 earlier this month, riding the wave of AI-driven optimism in the semiconductor sector. But like most chip and tech stocks, the ...

Google Stock Has Been the Clear AI Winner—and the Gains Could Keep Coming The company’s shares have gained 70% since Barron’s recommended them in December. They’re worth holding despite the jump.